
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Beneficial Role of Probiotic Lactobacillus in Respiratory Diseases
Tingfeng Du, Aihua Lei, Naiyu Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Tingfeng Du, Aihua Lei, Naiyu Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Chiara Mazziotta, Mauro Tognon, Fernanda Martini, et al.
Cells (2023) Vol. 12, Iss. 1, pp. 184-184
Open Access | Times Cited: 346
Chiara Mazziotta, Mauro Tognon, Fernanda Martini, et al.
Cells (2023) Vol. 12, Iss. 1, pp. 184-184
Open Access | Times Cited: 346
Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses
Sonakshi Rastogi, Aditi Singh
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Sonakshi Rastogi, Aditi Singh
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132
Cell-free supernatants from Lactobacillus strains exert antibacterial, antibiofilm, and antivirulence activity against Pseudomonas aeruginosa from cystic fibrosis patients
Arianna Pompilio, Esingül Kaya, Veronica Lupetti, et al.
Microbes and Infection (2024) Vol. 26, Iss. 4, pp. 105301-105301
Open Access | Times Cited: 13
Arianna Pompilio, Esingül Kaya, Veronica Lupetti, et al.
Microbes and Infection (2024) Vol. 26, Iss. 4, pp. 105301-105301
Open Access | Times Cited: 13
Keystone Bacteria Dynamics in Chronic Obstructive Pulmonary Disease (COPD): Towards Differential Diagnosis and Probiotic Candidates
Azadeh KavianFar, Hamidreza Taherkhani, Hossein Lanjanian, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42719-e42719
Open Access | Times Cited: 1
Azadeh KavianFar, Hamidreza Taherkhani, Hossein Lanjanian, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42719-e42719
Open Access | Times Cited: 1
Probiotic Lactobacillus plantarum GUANKE effectively alleviates allergic rhinitis symptoms by modulating functions of various cytokines and chemokines
Haijun Han, Guoliang Chen, Bin Zhang, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 7
Haijun Han, Guoliang Chen, Bin Zhang, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 7
An orally administered bacterial membrane protein nanodrug ameliorates doxorubicin cardiotoxicity through alleviating impaired intestinal barrier
Zhen Li, Junyue Xing, Xiaohan Ma, et al.
Bioactive Materials (2024) Vol. 37, pp. 517-532
Open Access | Times Cited: 7
Zhen Li, Junyue Xing, Xiaohan Ma, et al.
Bioactive Materials (2024) Vol. 37, pp. 517-532
Open Access | Times Cited: 7
The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections
Emily A Sey, Adilia Warris
Oxford Open Immunology (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Emily A Sey, Adilia Warris
Oxford Open Immunology (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Intact lung tissue and bronchoalveolar lavage fluid are both suitable for the evaluation of murine lung microbiome in acute lung injury
Lijun Zheng, Chengjun Liu, Hongjing Wang, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Lijun Zheng, Chengjun Liu, Hongjing Wang, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Does “all disease begin in the gut”? The gut-organ cross talk in the microbiome
Prem Prashant Chaudhary, Mahaldeep Kaur, Ian A. Myles
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 5
Prem Prashant Chaudhary, Mahaldeep Kaur, Ian A. Myles
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 5
The role of the microbiota and metabolites in the treatment of pulmonary fibrosis with UC-MSCs: Integrating fecal metabolomics and 16S rDNA analysis
Yukai Luo, Shuang Zhou, Xiaojing Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313989-e0313989
Open Access
Yukai Luo, Shuang Zhou, Xiaojing Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313989-e0313989
Open Access
Digestion Characteristics and Probiotic Activity of An Tea Polysaccharides: Promoting Lactobacillus and Bifidobacterium In Vitro and In Vivo
Yuning Sun, S. J. Li, Jie Cao, et al.
Fermentation (2025) Vol. 11, Iss. 2, pp. 97-97
Open Access
Yuning Sun, S. J. Li, Jie Cao, et al.
Fermentation (2025) Vol. 11, Iss. 2, pp. 97-97
Open Access
Innovative Therapeutic Strategies for Asthma: The Role of Gut Microbiome in Airway Immunity
Yaqin Liu, Junjie Dai, Guibao Zhou, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 257-267
Open Access
Yaqin Liu, Junjie Dai, Guibao Zhou, et al.
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 257-267
Open Access
Activation of Sirt1 by acetate alleviates silicofibrosis: Contribution of the gut microbiota
Weiliang Zhang, Xue‐Jie Qi, Mingming Han, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117969-117969
Open Access
Weiliang Zhang, Xue‐Jie Qi, Mingming Han, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117969-117969
Open Access
Exacerbation of Asthma Airway Inflammation by HOCl Exposure: Insights from Fecal Microbiota and Metabolomics
Yingjun Chen, S. Stephen Yi, Qian Wang, et al.
Journal of Hazardous Materials (2025) Vol. 490, pp. 137796-137796
Closed Access
Yingjun Chen, S. Stephen Yi, Qian Wang, et al.
Journal of Hazardous Materials (2025) Vol. 490, pp. 137796-137796
Closed Access
Gerobiotics: Exploring the Potential and Limitations of Repurposing Probiotics in Addressing Aging Hallmarks and Chronic Diseases
A.G.M.Sofi Uddin Mahamud, Ishtiak Ahammed Tanvir, Md. Ehsanul Kabir, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
A.G.M.Sofi Uddin Mahamud, Ishtiak Ahammed Tanvir, Md. Ehsanul Kabir, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Lacticaseibacillus rhamnosus OF44 with Potent Antimicrobial Activity: Evidence from the Complete Genome and Phenotypic Analysis
Jinhong Wang, Zhihui Ma, Qianyue Xu, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Jinhong Wang, Zhihui Ma, Qianyue Xu, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Intratracheal Candida administration induced lung dysbiosis, activated neutrophils, and worsened lung hemorrhage in pristane-induced lupus mice
Thansita Bhunyakarnjanarat, Kanyarat Udompornpitak, Dhammika Leshan Wannigama, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Thansita Bhunyakarnjanarat, Kanyarat Udompornpitak, Dhammika Leshan Wannigama, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effect of Probiotic Product Containing Heyndrickxia coagulans TBC169 on Hyperuricemia in Rats
Lixiao Duan, Xingting Zhang, Dandan Wang, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Lixiao Duan, Xingting Zhang, Dandan Wang, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Nano selenium-enriched probiotic Lactobacillus enhances alum adjuvanticity and promotes antigen-specific systemic and mucosal immunity
Runhang Liu, Weijiao Sun, Tianzhi Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Runhang Liu, Weijiao Sun, Tianzhi Sun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Lactobacillus Probiotic Strains Differ in Their Ability to Adhere to Human Lung Epithelial Cells and to Prevent Adhesion of Clinical Isolates of Pseudomonas aeruginosa from Cystic Fibrosis Lung
Giovanna Batoni, Esingül Kaya, Elisa Catelli, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1707-1707
Open Access | Times Cited: 11
Giovanna Batoni, Esingül Kaya, Elisa Catelli, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1707-1707
Open Access | Times Cited: 11
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice
Chung‐Ming Chen, Yu‐Chen S. H. Yang, Hsiu‐Chu Chou, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 11
Chung‐Ming Chen, Yu‐Chen S. H. Yang, Hsiu‐Chu Chou, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 11
Bacterial community and diversity in the rumen of 11 Mongolian cattle as revealed by 16S rRNA amplicon sequencing
Yijiu Jia, Yali Shi, Huiyan Qiao
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Yijiu Jia, Yali Shi, Huiyan Qiao
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis
Mengdi Sun, Feiyu Zhang, Fang Lü, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Mengdi Sun, Feiyu Zhang, Fang Lü, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota
Haibo Hu, Fengchan Wang, Ping Han, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Haibo Hu, Fengchan Wang, Ping Han, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Global research trends between gut microbiota and lung cancer from 2011 to 2022: A bibliometric and visualization analysis
Haitao Chen, YUEBIAO LAI, Chenxiao Ye, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Haitao Chen, YUEBIAO LAI, Chenxiao Ye, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10